A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
NCT03990805 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 260
Last updated 2022-09-28
Summary
The purpose of this study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.
Conditions
- Degenerative Arthritis
- Knee Osteoarthritis
Interventions
- BIOLOGICAL
-
JOINTSTEM
JOINTSTEM Autologous Adipose Tissue derived MSCs 1x10\^8cells/(saline), 1 time injection
- DRUG
-
saline
saline, 1 time injection
Sponsors & Collaborators
-
R-Bio
lead INDUSTRY
Principal Investigators
-
KANGIL KIM, M.D., Ph.D. · KyungHee University Gangdong Hospital
-
WOOSUK LEE, M.D., Ph.D. · Gangnam Severance Hospital
-
SUNCHUL HWANG, M.D., Ph.D. · Gyeongsang National University Hospital
-
SANGJUN SONG, M.D., Ph.D. · Kyunghee University Medical Center
-
KICHEOR BAE, M.D., Ph.D. · Keimyung University Dongsan Medical Center
-
YOUNGWAN MOON, M.D., Ph.D. · Samsung Medical Center
-
JUHONG LEE, M.D., Ph.D. · Chonbuk National University Hospital
-
HANJUN LEE, M.D., Ph.D. · Chunang University Hospital
-
EUISUNG CHOI, M.D., Ph.D. · Chungbuk National University Hospital
-
YONG IN, M.D., Ph.D. · Seoul St. Mary's Hospital
-
KWANKYU PARK, M.D., Ph.D. · Yonsei University
-
OOGJIN SHON, M.D., Ph.D. · Yeungnam University Hospital
-
MYUNGCHUL LEE, M.D., Ph.D. · Seoul National University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-11
- Primary Completion
- 2020-12-15
- Completion
- 2020-12-15
Countries
- South Korea
Study Locations
More Related Trials
-
Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee
NCT02544802 ·Status: COMPLETED ·Phase: PHASE1
-
Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.
NCT03000712 ·Status: COMPLETED ·Phase: NA
-
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis
NCT01809769 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy
NCT05933434 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Adipose-derived Mesenchymal Stem Cells in Osteoarthritis
NCT03869229 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis
NCT06570291 ·Status: RECRUITING ·Phase: PHASE3
-
Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy
NCT04825730 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis
NCT02838069 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-articular Injection of MSCs in Treatment of Knee OA
NCT03028428 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stromal Cell Product (RegStem)
NCT03007576 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
NCT02674399 ·Status: COMPLETED ·Phase: PHASE2
-
The Comparison of Efficacy and Safety of the Mesenchymal Stem Cells From Adipose and Hyaluronic Acid
NCT03357575 ·Status: UNKNOWN ·Phase: NA
-
Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis
NCT02805855 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis
NCT06084988 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety Study of Intra-Articular Injections of Autologous Peripheral Blood Stem Cells Following Subchondral Drilling Surgery for the Treatment of Articular Cartilage Injury in the Knee
NCT03101163 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis
NCT03943576 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis
NCT01300598 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Study of Intra Articular Injection of Catholic MASTER Cell (Bone Marrow Derived Mesenchymal Stem Cell) in Knee Osteoarthritis
NCT04240873 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis
NCT02846675 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effects of Stromal Vascular Fraction and Mesenchymal Stem Cells as Intra-articular Injection in Knee Joint Osteoarthritis
NCT03164083 ·Status: WITHDRAWN ·Phase: PHASE2
-
Knee Osteoarthritis Treatment With Adipose-derived Stem Cells: Phase II Clinical Trial
NCT03308006 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee
NCT03940950 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
NCT03014401 ·Status: RECRUITING ·Phase: NA
-
Adipose-tissue-derived Total-Stromal-cells (TOST) Therapy in Knee Osteoarthritis
NCT05280002 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury
NCT03955497 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2